President, CEO, & Director, Synthorx
Dr. Shawver is a Biotech executive with more than 25 years of experience in the development of drugs for cancer and other serious diseases. Currently serving on the Board of Relay Therapeutics and Cleave Therapeutics (Chair), she recently was President and CEO of Synthorx, Inc from late 2017 through its acquisition by Sanofi in January 2020. Prior to Synthorx, Dr. Shawver was CEO of Cleave Biosciences from 2011-2017. Previously, she was an Entrepreneur in Residence for 5AM Ventures from 2010 – 2011, CEO and Director of Phenomix from 2002 – 2010 and President of SUGEN Inc. from 2000 after holding various positions since 1992. Prior to SUGEN, she was employed at Berlex Biosciences, formerly known as Triton Biosciences. Dr. Shawver is the Founder of The Clearity Foundation, a nonprofit organization helping women with ovarian cancer patients improve their treatment options. Shawver received her PhD in Pharmacology and a BS degree in Microbiology, both from the University of Iowa.